Lanospharma Laboratories Co.,Ltd

语言/Language: 中文/English
维生素 D2 derivatives
Vitamin D4
维生素 D3 衍生物

 

 

 

维生素 D4,511-28-4,维生素 D2 衍生物
维生素 D4
Vitamin D4,511-28-4
产品名称
维生素 D4
其他名称
22-Dihydroergocalciferol;22,23-Dihydroergocalciferol
英文名称
Vitamin D4
CAS 号码
511-28-4?
分子式
C28H46O
分子式
398.6704
分析报告
Vitamin D4,511-28-4,Vitamin D2 derivative
安全数据
Vitamin D4,511-28-4,Vitamin D2 derivative
View via PDF file
vitamin d4,511-28-4
检测指标
外观
白色或类白色粉末
白色粉末
鉴定
高效液相色谱和红外检测
符合要求
杂质
单个杂质: 小于:0.1%
0.69%
总杂质:小于:3.0%
1.7%
纯度
TLC:One spot
符合要求
HPLC:97.0%
98.5%
含量
97.0% - 103.0%
98.1%
 
购买维生素D4(Vitamin D4),511-28-4客户:

Katherine M. Phillips?in Virginia Polytechnic Institute and State University,USA has purchased Vitmain D4,511-28-4 from us in 2010 and a paper named <<Vitamin D4?in Mushrooms>> has been published in 2012.Please kindly find following link to learn more information:

Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411670/

Contact us for more information
Chemical information
Compound Name*
CAS No. "N/A" if the CAS not available*
Quantity*
Contact information
Contact person*
Email Address *
Tel No.*
Company or Organization Name*
Shipping Address*
Country
Remarks

<Privacy policy: the contact information will be only used for this business contact>

Related Vitamin D2 derivatives
 
Patent Disclaimer
PD1
Products protected by valid patents are not offered for sale in jurisdictions where the sale of such?products constitutes a patent infringement. The current list only reflects the products and?technologies that are available, under development: note that some products may be developed or produced for internal and experimental uses with no commercal aim.
PD2
Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and development quantities.
PD3
the buyer assumes responsibility of all patent considerations in the use of
Lanos' Pharmaceutical Co.,LTD ’s Vitamin D4,511-28-4.
PD4
R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other countries.